Exploration of chemistry and biology of naturally-occurring and synthetic organic molecules with therapeutic potential in infective, neurodegenerative, neuropsychiatric, cancer, and parasitic diseases is the main topic of Prof. Campiani research activity. His interests include R&D for rare diseases, target selection and the rational design of innovative drugs, the discovery of new synthetic methodologies and general strategies for synthesis, bioinformatics, the study of important structure-function relationships, and metabolomic analyses for food matrices for traceability and authentication in agrifood production.
CAMPIANI GIUSEPPE
Presentation
Office hours
-
Friday from 10:00 to 11:00Place: Dipartimento Farmaco Chimico Tecnologico room/stanza 10154
Contacts
0577232239 [int.2239]
Teaching activities
Completion accademic year: 2019/2020
Completion accademic year: 2018/2019
Completion accademic year: 2017/2018
Completion accademic year: 2016/2017
Research
Ultime pubblicazioni:
-
Tudino, V., Mellini, M., Milioni, L., Carullo, G., Rossi, S., Giammarino, F.M.P.R., et al. (2026). Quinazolinone-Based PqsR Modulators Suppress Quorum-Sensing–Driven Virulence in
Pseudomonas aeruginosa. ACS INFECTIOUS DISEASES [10.1021/acsinfecdis.5c01128]. - view more - Carullo, G., Falbo, F., Tudino, V., Song, J., Fava, M., Fontana, A., et al. (2026). Targeting class I histone deacetylases triggers antitumor responses in colorectal cancer in vitro and in vivo. JOURNAL OF MEDICINAL CHEMISTRY, 69(2), 1049-1074 [10.1021/acs.jmedchem.5c02237]. - view more
- Fedeli, R., Ranzato, E., Martinotti, S., Basilicata, M.G., Marotta, L., Fava, M., et al. (2025). Unveiling Wound Healing Properties of Biostimulated Walnut Kernel Extracts via Epithelial Mesenchymal Transition: Switching a Nutritional Matrix into a Therapeutic Remedy. ANTIOXIDANTS, 14(9) [10.3390/antiox14091079]. - view more
- Cursaro, I., Milioni, L., Eslami, K., Sirous, H., Carullo, G., Gemma, S., et al. (2025). Targeting N‐Methyl‐lysine Histone Demethylase KDM4 in Cancer: Natural Products Inhibitors as a Driving Force for Epigenetic Drug Discovery. CHEMMEDCHEM, 20(4) [10.1002/cmdc.202400682]. - view more
- Cursaro, I., Ciccone, V., Tudino, V., Papulino, C., Scalvini, L., Donnini, S., et al. (2025). Reversing TGF-β1-induced fibrotic phenotype in human lung fibroblasts using a PROTAC tool derived from an indoline-based HDAC6 inhibitor. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY REPORTS, 14 [10.1016/j.ejmcr.2025.100276]. - view more